Literature DB >> 2764544

Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.

J C Pioget1, M Wolff, E Singlas, M J Laisne, B Clair, B Regnier, F Vachon.   

Abstract

The penetration of ofloxacin was studied in 22 patients with purulent meningitis or ventriculitis treated with conventional antibiotics. Three successive doses of 200 mg were infused at 12-h intervals during the acute stage of the disease. Ten patients received three additional doses when the meninges were considered to be healed. Cerebrospinal fluid (CSF) was drawn 0.5, 3, 6, or 12 h after the last infusion. Serial plasma and CSF samples were also obtained from patients with ventricular drainage. Concentrations in CSF ranged from 0.96 +/- 0.15 to 1.80 +/- 0.29 microgram/ml, depending on sampling time. The percentage of penetration in ventricular fluid, expressed as the ratio of the CSF area under the curve from 0 to 12 h to the plasma area under the curve from 0 to 12 h, was 73 +/- 6. Ofloxacin readily diffuses into CSF of patients with meningitis or ventriculitis and may be useful for treatment of CSF infections caused by susceptible pathogens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764544      PMCID: PMC284258          DOI: 10.1128/AAC.33.6.933

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Ofloxacin penetration into cerebrospinal fluid.

Authors:  M Drancourt; H Gallais; D Raoult; E Estrangin; M N Mallet; P De Micco
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

2.  Study of the cerebrospinal fluid penetrability of ofloxacin.

Authors:  G Stübner; W Weinrich; U Brands
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 3.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

4.  Hospital-acquired bacterial meningitis in neurosurgical patients.

Authors:  F J Buckwold; R Hand; R R Hansebout
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

Review 5.  Principles in the treatment of bacterial meningitis.

Authors:  M G Täuber; M A Sande
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

6.  In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.

Authors:  T Kumada; H C Neu
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

7.  Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis.

Authors:  J P Stahl; J Croize; M A Lefèbvre; J P Bru; A Guyot; D Leduc; J B Fourtillan; M Micoud
Journal:  Infection       Date:  1986       Impact factor: 3.553

8.  Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis.

Authors:  M Wolff; B Regnier; C Daldoss; M Nkam; F Vachon
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  8 in total
  4 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

Authors:  R Nau; M Kinzig; T Dreyhaupt; H Kolenda; F Sörgel; H W Prange
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

4.  High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.

Authors:  G M Auten; L C Preheim; M Sookpranee; M J Bittner; T Sookpranee; A Vibhagool
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.